HomeARCH • CVE
add
Arch Biopartners Inc
Previous close
$1.74
Day range
$1.70 - $1.78
Year range
$1.36 - $2.56
Market cap
112.20M CAD
Avg Volume
10.00K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 117.86K | -60.47% |
Operating expense | 347.24K | -57.37% |
Net income | -416.30K | 46.85% |
Net profit margin | -353.20 | -34.44% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 54.85K | -81.88% |
Total assets | 533.53K | -16.17% |
Total liabilities | 4.79M | -24.50% |
Total equity | -4.26M | — |
Shares outstanding | 69.38M | — |
Price to book | -29.00 | — |
Return on assets | -86.24% | — |
Return on capital | 49.52% | — |
Cash Flow
Net change in cash
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -416.30K | 46.85% |
Cash from operations | -903.06K | -65.29% |
Cash from investing | — | — |
Cash from financing | 954.93K | 5,295.72% |
Net change in cash | 51.88K | 109.81% |
Free cash flow | -688.94K | -175.37% |
About
Founded
1983
Headquarters
Website
